Dai et al. (2022) devised a dPCR protocol for cff-DNA enrichment in maternal plasma from normal pregnancies and evaluated its clinical utility in NIPT for trisomy 21 using 283 high-risk maternal plasma samples. This evidence concerns the gene HCFC1 and trisomy 21.